{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:55:20Z","timestamp":1781502920065,"version":"3.54.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebrovascular thrombosis is an uncommon but potentially life-threatening complication of chemotherapy in children with acute lymphoblastic leukemia (ALL). Although PEG-asparaginase\u2013associated thrombosis has been widely recognized, the temporal pattern, laboratory evolution, and management characteristics of cerebrovascular events remain incompletely described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective single-center case series of pediatric patients with acute lymphoblastic leukemia (ALL) treated between January 2018 and December 2025. Clinical records, serial coagulation parameters, neuroimaging findings, treatment strategies, and outcomes of patients who experienced cerebrovascular thrombotic events during chemotherapy were reviewed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1,138 pediatric patients with ALL treated during the study period, six developed radiologically confirmed cerebrovascular thrombosis (incidence proportion, 0.53%; median age, 10 years). Five patients developed cerebral venous sinus thrombosis (CVST) and one developed acute ischemic stroke (AIS). Five of six events in this small cohort occurred within 5\u201317 days after PEG-asparaginase administration. At symptom onset, all patients exhibited markedly elevated D-dimer levels and reduced antithrombin III (AT-III) activity. Following treatment, D-dimer levels declined within 1\u20133 days, whereas AT-III activity recovered more gradually over 5\u201313 days. Four patients with CVST received therapeutic low-molecular-weight heparin and achieved favorable neurological outcomes. One patient with AIS underwent successful mechanical thrombectomy with substantial neurological improvement. No recurrent thrombotic events were observed during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this case series, cerebrovascular thrombosis during pediatric ALL therapy showed a distinct temporal clustering pattern within 5\u201317 days after PEG-asparaginase exposure and was consistently associated with reduced AT-III activity and elevated D-dimer levels. These findings suggest a potential high-risk period during which focused coagulation monitoring may facilitate earlier diagnosis and timely therapeutic intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1829820","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:36:59Z","timestamp":1781501819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cerebrovascular thrombosis during pediatric ALL therapy: a case series highlighting temporal association with PEG-asparaginase exposure"],"prefix":"10.3389","volume":"14","author":[{"given":"Chen","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Suzhou Wujiang District Children\u2019s Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"JCO"},{"key":"B3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","article-title":"Methotrexate-Induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia","volume":"32","author":"Bhojwani","year":"2014","journal-title":"JCO"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e30425","DOI":"10.1002\/pbc.30425","article-title":"Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: a multicenter study","volume":"70","author":"Guzelkucuk","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","article-title":"Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years","volume":"131","author":"Rank","year":"2018","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","article-title":"The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols","volume":"152","author":"Grace","year":"2011","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"828702","DOI":"10.3389\/fped.2022.828702","article-title":"Thrombosis complications in pediatric acute lymphoblastic leukemia: risk factors, management, and prevention: is there any role for pharmacologic prophylaxis?","volume":"10","author":"Rodriguez","year":"2022","journal-title":"Front Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1182\/blood-2002-06-1901","article-title":"Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration","volume":"101","author":"Nowak-G\u00f6ttl","year":"2003","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.thromres.2013.12.021","article-title":"Venous thromboembolism in children with cancer \u2013 a population-based cohort study","volume":"133","author":"Walker","year":"2014","journal-title":"Thromb Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/leu.2012.290","article-title":"The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia","volume":"27","author":"Truelove","year":"2013","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e27729","DOI":"10.1002\/pbc.27729","article-title":"Antithrombin and fibrinogen levels as predictors for plasma L-asparaginase activity in children with acute lymphoblastic leukemia","volume":"66","author":"Merlen","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12887-017-0877-x","article-title":"TropicALL study: thromboprophylaxis in children treated for acute lymphoblastic leukemia with low-molecular-weight heparin: a multicenter randomized controlled trial","volume":"17","author":"Klaassen","year":"2017","journal-title":"BMC Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamaneurol.2019.3291","article-title":"Feasibility, safety, and outcome of endovascular recanalization in childhood stroke: the save ChildS study","volume":"77","author":"Sporns","year":"2020","journal-title":"JAMA Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e29210","DOI":"10.1002\/pbc.29210","article-title":"Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: new risk factors to consider","volume":"68","author":"El-Khoury","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"104347","DOI":"10.1016\/j.critrevonc.2024.104347","article-title":"A systematic review and meta-analysis of the effectiveness of primary thromboprophylaxis in acute lymphoblastic leukemia during early-phase therapy including asparaginase or its prolonged form","volume":"197","author":"Hu","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/rth2.12182","article-title":"Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: risk factors and effect on prognosis","volume":"3","author":"Klaassen","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"B18","doi-asserted-by":"publisher","first-page":"108116","DOI":"10.1016\/j.pharmthera.2022.108116","article-title":"Endothelial dysfunction as a complication of anti-cancer therapy","volume":"237","author":"Terwoord","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.thromres.2018.01.019","article-title":"Thrombosis in pediatric patients with leukemia","volume":"164","author":"Levy-Mendelovich","year":"2018","journal-title":"Thromb Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/brain\/awh412","article-title":"Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome","volume":"128","author":"Sebire","year":"2005","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00381-020-04829-7","article-title":"Treatment of pediatric cerebral venous sinus thromboses: the role of anticoagulation","volume":"36","author":"Shlobin","year":"2020","journal-title":"Childs Nerv Syst"},{"key":"B22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/jamaneurol.2023.2303","article-title":"Association between thrombectomy and functional outcomes in pediatric patients with acute ischemic stroke from large vessel occlusion","volume":"80","author":"Bhatia","year":"2023","journal-title":"JAMA Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00062-022-01246-y","article-title":"Mechanical thrombectomy for pediatric large vessel occlusions: a systematic review and meta-analysis","volume":"33","author":"Bilgin","year":"2023","journal-title":"Clin Neuroradiol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1829820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:37:00Z","timestamp":1781501820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1829820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":23,"alternative-id":["10.3389\/fped.2026.1829820"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1829820","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"article-number":"1829820"}}